tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

HCM Stock Latest News

Hutchmed announces new, updated data from sovleplenib ESLIM-01 trial
The FlyHutchmed announces new, updated data from sovleplenib ESLIM-01 trial
15d ago
HCM
Hutchmed to receive $20M milestone payment from Takeda for Fruzaqla sales
PremiumThe Fly
Hutchmed to receive $20M milestone payment from Takeda for Fruzaqla sales
21d ago
HCM
TAK
Hutchmed announces results from SAVANNAH trial
PremiumThe Fly
Hutchmed announces results from SAVANNAH trial
1M ago
AZN
HCM
Hutchmed, Takeda receive Japan MHLW approval to manufacture and market Fruzaqla
PremiumThe Fly
Hutchmed, Takeda receive Japan MHLW approval to manufacture and market Fruzaqla
2M ago
HCM
Hutchmed withdraws NDA in China for fruquintinib in combination with paclitaxel
PremiumThe Fly
Hutchmed withdraws NDA in China for fruquintinib in combination with paclitaxel
3M ago
HCM
Hutchmed reiterates 2024 guidance for Oncology/Immunology revenue $300M-$400M
PremiumThe FlyHutchmed reiterates 2024 guidance for Oncology/Immunology revenue $300M-$400M
4M ago
HCM
Hutchmed reports 1H revenue $305.7M vs. $532.9M last year
Premium
The Fly
Hutchmed reports 1H revenue $305.7M vs. $532.9M last year
4M ago
HCM
HUTCHMED’s Cancer Drug Fast-Tracked in China
Premium
Company Announcements
HUTCHMED’s Cancer Drug Fast-Tracked in China
5M ago
6K
HCM
Hutchmed announces FRUTIGA results published in Nature Medicine
PremiumThe Fly
Hutchmed announces FRUTIGA results published in Nature Medicine
6M ago
HCM
Hutchmed initiated with a Buy at HSBC
PremiumThe Fly
Hutchmed initiated with a Buy at HSBC
6M ago
HCM
HUTCHMED’s Breakthroughs in Hematology Spotlighted
PremiumCompany Announcements
HUTCHMED’s Breakthroughs in Hematology Spotlighted
6M ago
6K
HCM
Hutchmed chairman Simon To retires, Dan Eldar to succeed
PremiumThe Fly
Hutchmed chairman Simon To retires, Dan Eldar to succeed
6M ago
HCM
Hutchmed initiated with a Buy at Bocom
PremiumThe FlyHutchmed initiated with a Buy at Bocom
6M ago
HCM
HUTCHMED Launches Innovative Cancer Treatment Trial
Premium
Company Announcements
HUTCHMED Launches Innovative Cancer Treatment Trial
6M ago
6K
HCM
Hutchmed initiates Phase 2/3 trial of Surufatinib and Camrelizumab combination
Premium
The Fly
Hutchmed initiates Phase 2/3 trial of Surufatinib and Camrelizumab combination
6M ago
HCM
Hutchmed Shareholders Approve All AGM Resolutions
PremiumCompany Announcements
Hutchmed Shareholders Approve All AGM Resolutions
7M ago
6K
HCM
HUTCHMED Welcomes New Board Member Expertise
PremiumCompany Announcements
HUTCHMED Welcomes New Board Member Expertise
7M ago
6K
HCM
HUTCHMED Nears EU Approval for Cancer Drug
PremiumCompany Announcements
HUTCHMED Nears EU Approval for Cancer Drug
7M ago
6K
HCM
Hutchmed announces positive CHMP opinion for fruquintinib
PremiumThe Fly
Hutchmed announces positive CHMP opinion for fruquintinib
7M ago
HCM
TAK
HUTCHMED Announces Key Managerial LTIP Vesting
PremiumCompany AnnouncementsHUTCHMED Announces Key Managerial LTIP Vesting
7M ago
6K
HCM
HUTCHMED to Unveil New Cancer Drug Data at AACR 2024
Premium
Company Announcements
HUTCHMED to Unveil New Cancer Drug Data at AACR 2024
8M ago
6K
HCM
New Hope in Advanced Endometrial Cancer Treatment
Premium
Company Announcements
New Hope in Advanced Endometrial Cancer Treatment
8M ago
6K
HCM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >